STUDY OBJECTIVES: To investigate and elucidate the role of GABA(A) receptor subunits, specifically the 2 genetic markers at the GABA(A) α1 and GABA(A) α6 receptors, in zolpidem-induced complex sleep behaviors (CSBs). DESIGN: Genetic association study. SETTING: Kaohsiung Medical University-affiliated hospitals, Kaohsiung, Taiwan. PATIENTS: 30 zolpidem-induced CSB subjects and 37 controls. INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: The χ(2) test demonstrated an association between the A15G variant at the GABA(A) α1 receptor subunit gene and zolpidem-induced CSBs (P = 0.007). The adjusted odds ratio of the GABA(A) α1 receptor subunit genotype for the risk of zolpidem-induced CSBs was approximately 10 (OR = 9.99, 95% CI = 1.82, 74.87; P = 0.013). CONCLUSIONS: The finding reveals that the A15G variant at the GABA(A) α1 receptor subunit gene confers a high risk of zolpidem-induced CSBs and may be considered in clinical services.
STUDY OBJECTIVES: To investigate and elucidate the role of GABA(A) receptor subunits, specifically the 2 genetic markers at the GABA(A) α1 and GABA(A) α6 receptors, in zolpidem-induced complex sleep behaviors (CSBs). DESIGN: Genetic association study. SETTING: Kaohsiung Medical University-affiliated hospitals, Kaohsiung, Taiwan. PATIENTS: 30 zolpidem-induced CSB subjects and 37 controls. INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: The χ(2) test demonstrated an association between the A15G variant at the GABA(A) α1 receptor subunit gene and zolpidem-induced CSBs (P = 0.007). The adjusted odds ratio of the GABA(A) α1 receptor subunit genotype for the risk of zolpidem-induced CSBs was approximately 10 (OR = 9.99, 95% CI = 1.82, 74.87; P = 0.013). CONCLUSIONS: The finding reveals that the A15G variant at the GABA(A) α1 receptor subunit gene confers a high risk of zolpidem-induced CSBs and may be considered in clinical services.
Authors: Y T Chang; H S Sun; C S J Fann; C-J Chang; Z H Liao; J L Huang; E W Loh; W Y Yu; A T A Cheng Journal: Mol Psychiatry Date: 2002 Impact factor: 15.992
Authors: M R Nelson; S-A Bacanu; M Mosteller; L Li; C E Bowman; A D Roses; E H Lai; M G Ehm Journal: Pharmacogenomics J Date: 2008-02-26 Impact factor: 3.550
Authors: James K Rowlett; Donna M Platt; Snjezana Lelas; John R Atack; Gerard R Dawson Journal: Proc Natl Acad Sci U S A Date: 2005-01-11 Impact factor: 11.205
Authors: Diane Merino; Alexandre O Gérard; Elise K Van Obberghen; Nouha Ben Othman; Eric Ettore; Bruno Giordana; Delphine Viard; Fanny Rocher; Alexandre Destere; Michel Benoit; Milou-Daniel Drici Journal: J Clin Med Date: 2022-07-04 Impact factor: 4.964